High-Risk Conditions for Which ABPM May Be Useful
Condition . | Rationale . |
---|---|
Secondary HTN | Severe ambulatory HTN or nocturnal HTN indicates higher likelihood of secondary HTN161,167 |
CKD or structural renal abnormalities | Evaluate for MH or nocturnal HTN,168,–172 better control delays progression of renal disease173 |
T1DM and T2DM | Evaluate for abnormal ABPM patterns,174,175 better BP control delays the development of MA176,–178 |
Solid-organ transplant | Evaluate for MH or nocturnal HTN, better control BP179,–188 |
Obesity | Evaluate for WCH and MH23,189,–192 |
OSAS | Evaluate for nondipping and accentuated morning BP surge43,46,193,194 |
Aortic coarctation (repaired) | Evaluate for sustained HTN and MH58,112,113 |
Genetic syndromes associated with HTN (neurofibromatosis, Turner syndrome, Williams syndrome, coarctation of the aorta) | HTN associated with increased arterial stiffness may only be manifest with activity during ABPM58,195 |
Treated hypertensive patients | Confirm 24-h BP control155 |
Patient born prematurely | Evaluate for nondipping196 |
Research, clinical trials | To reduce sample size197 |
Condition . | Rationale . |
---|---|
Secondary HTN | Severe ambulatory HTN or nocturnal HTN indicates higher likelihood of secondary HTN161,167 |
CKD or structural renal abnormalities | Evaluate for MH or nocturnal HTN,168,–172 better control delays progression of renal disease173 |
T1DM and T2DM | Evaluate for abnormal ABPM patterns,174,175 better BP control delays the development of MA176,–178 |
Solid-organ transplant | Evaluate for MH or nocturnal HTN, better control BP179,–188 |
Obesity | Evaluate for WCH and MH23,189,–192 |
OSAS | Evaluate for nondipping and accentuated morning BP surge43,46,193,194 |
Aortic coarctation (repaired) | Evaluate for sustained HTN and MH58,112,113 |
Genetic syndromes associated with HTN (neurofibromatosis, Turner syndrome, Williams syndrome, coarctation of the aorta) | HTN associated with increased arterial stiffness may only be manifest with activity during ABPM58,195 |
Treated hypertensive patients | Confirm 24-h BP control155 |
Patient born prematurely | Evaluate for nondipping196 |
Research, clinical trials | To reduce sample size197 |